Kidney cancer therapy candidate, TLX250 (177Lu-girentuximab): The Company was granted a pre-investigational new drug (pre-IND) meeting with the U.S. Food and Drug Administration (FDA) in Q4 2024, to ...
ShareThe announcement that Dr Ngozi Okonjo-Iweala was named by Forbes as one of the world’s most powerful women in 2024 for the eighth time is not just a testament to her remarkable career — it is a ...
This vector design is easy to edit according to your company's needs. Royalty-free licenses let you pay once to use copyrighted images and video clips in personal and commercial projects on an ongoing ...
BeiGene (BGNE), a global oncology company that intends to change its name to BeOne Medicines, announced the U.S. FDA has approved Tevimbra in combination with platinum and fluoropyrimidine-based ...